3.0
Nov 29, 2023
Former employee, more than 1 year
Recommend
CEO approval
Business Outlook
Pros
Great place to work overall. Management is very engaged and provides valuable feedback. Patient-focused organization.
Cons
Culture shifted after the new CEO, Matt took over. The main drug will go generic next year and likely impact profits. Not a very robust pipeline either. Very little room for advancement.